Mycophenolate mofetil for the transplanted kidney?

Drug and Therapeutics Bulletin

Volumn 35, Issue 5, 1997, Pages 38-40

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACICLOVIR; ANTACID AGENT; AZATHIOPRINE; COLESTYRAMINE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ABDOMINAL PAIN; CLINICAL TRIAL; DIARRHEA; DRUG COST; GASTROINTESTINAL SYMPTOM; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; META ANALYSIS; SEPSIS; SHORT SURVEY; VOMITING;

EID: 0030910322     PISSN: 00126543     EISSN: None     Source Type: Journal    
DOI: 10.1136/dtb.1997.35538     Document Type: Short Survey

References (9)

1. Almond PS, Matas A, Gillingham K, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993; 55: 752-7.
2. The Mycophenolate Mofetil Renal Refractory Rejection Study Group. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. Transplantation 1996; 61: 722-9.
3. Allison AC, Eugui EM. Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil. Immunol Rev 1993; 136: 5-28.
4. Shaw LM, Sollinger HW, Halloran P, et al. Mycophenolate mofetil; a report of the Consensus Panel. Ther Drug Monit 1995; 17: 690-9.
5. European Mycophenolate Mofetil Cooperative Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 1995; 345: 1321-5.
6. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 1996; 61: 1029-37.
7. Sollinger HW for the U.S. Renal Transplant Mycophenolate Mofetil Study Group. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 1995; 60: 225-32.
8. Epinette WW, Parker CM, Linn Jones E, Greist MC. Mycophenolic acid for psoriasis. J Am Acad Dermatol 1987; 17:962-71.
9. Zucker K, Esquenazi V, Rosen A et al. Unexpected augmentation of MMF pharmacokinetics in renal transplant patients receiving PROGRAF and Cell-Cept in combination therapy, and analogous in vitro findings. XVI International Congress of the Transplantation Society. August 25-30 1996. Barcelona [abstract 62].